Desrosiers defends live AIDS vaccine, urges monkey trial
Article Abstract:
Ronald C. Desrosiers, the Harvard University researcher who developed a live attenuated AIDS vaccine, urges both sides in the fiery debate over possible human tests of the vaccine to rein in their emotions and keep calm on the issue. In a letter to the Nature Medicine journal, Desrosiers takes a middle ground between using live attenuated HIV-1 strains as a vaccine approach for AIDS and refraining from putting humans at risk with a live retrovirus vaccine. He also contends in the letter that placebo-controlled safety testing of an SIV vaccine in rhesus monkeys should be a priority in 1999.
Publication Name: Vaccine Weekly
Subject: Health
ISSN: 1074-2921
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Tiered pricing: a solution to vaccine access?
Article Abstract:
A tiered pricing system has been recommended by World Bank health expert Amie Batson as a means to facilitate global access to vaccines, even for new products. Instead of waiting for a product to enter maturity, tiered pricing allows prices to be set for different markets early in the product lifecycle. To recover the costs of vaccine production and development, vaccines will be priced higher in richer countries and marginally in poorer countries. Meanwhile, public agencies tasked with distributing vaccines to the poorest of nations can avail of these products at a reduced price.
Publication Name: World Disease Weekly Plus
Subject: Health
ISSN:
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Long-term effects of multiple pregnancies on cardiac dimensions and systolic and diastolic function. part 2 A comparison between middle cerebral artery peak systolic velocity and amniotic fluid optical density at 450 nm in the prediction of fetal anemia
- Abstracts: With friends like these.... Are black nurses an endangered species?
- Abstracts: CDC sharpens tools for vaccine-safety surveillance. 2002 vaccine market: $7 billion. Unprecedented protection with prime/boost malaria vaccine
- Abstracts: Virus outbreak in Kenya linked to heavy rains. Three children die of chickenpox related complications. Persistent antibodies detected years after brief exposure
- Abstracts: Can the Accuracy of Abstracts Be Improved by Providing Specific Instructions?